Abstract
This paper deals with new trends in psychopharmacology. Our study on the incidence of psychiatric disorders on intensive care wards displays that basic knowledge about therapeutic profile, side-effects, and interaction with other drugs of recently released new drugs is also important for non-psychiatrics. We recall the serious side-effects of once or even still licensed drugs and present new therapeutic developments in the treatment of depression and psychosis.
| Translated title of the contribution | An up-date of clinical psychopharmacology |
|---|---|
| Original language | German |
| Journal | Intensivmedizin und Notfallmedizin |
| Volume | 29 |
| Issue number | SUPPL. 1 |
| Pages (from-to) | 30-41 |
| Number of pages | 12 |
| ISSN | 0175-3851 |
| Publication status | Published - 1992 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
-
SDG 10 Reduced Inequalities
Research Areas and Centers
- Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)
Fingerprint
Dive into the research topics of 'An up-date of clinical psychopharmacology'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver